Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 3/20 | 0.56 |
| ▸ | SELL | P14151 | 1/20 | 0.49 |
| ▸ | SELP | P16109 | 1/20 | 0.49 |
| ▸ | SIGLEC7 | Q9Y286 | 4/20 | 0.46 |
| ▸ | MAG | P20916 | 5/20 | 0.45 |
| ▸ | CD22 | P20273 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16839997 | 0.91 | NANP (0.58) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL18357290 | 0.91 | NANP (0.58) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL15087687 | 0.91 | NANP (0.58) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL6128016 | 0.91 | NANP (0.51) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL17300145 | 0.88 | NANP (0.60) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL29226229 | 0.88 | NANP (0.60) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL1487630 | 0.86 | NANP (0.58) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL29226109 | 0.86 | NANP (0.58) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL8472605 | 0.86 | NANP (0.58) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL29226021 | 0.86 | NANP (0.58) | NANPSELLSELPSIGLEC7MAG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220146514-A1 | METHODS AND KITS FOR THE DIAGNOSIS OF INFLUENZA | BECTON, DICKINSON AND COMPANY | 2022-05-12 | — | — | US | disclosed |
| US-11209433-B2 | Methods and kits for the diagnosis of influenza | BECTON, DICKINSON AND COMPANY (US) | 2021-12-28 | — | — | US | disclosed |
| US-20190339272-A1 | METHODS AND KITS FOR THE DIAGNOSIS OF INFLUENZA | BECTON, DICKINSON AND COMPANY | 2019-11-07 | — | — | US | disclosed |
| EP-2981618-B1 | METHODS AND KITS FOR THE DIAGNOSIS OF INFLUENZA | BECTON DICKINSON CO (US) | 2019-08-28 | — | — | EP | disclosed |
| US-10317404-B2 | Method and kits for the diagnosis of influenza | BECTON, DICKINSON AND COMPANY (US) | 2019-06-11 | — | — | US | disclosed |
| CN-108663518-A | Method and kit for diagnosing influenza | 贝克顿·迪金森公司 | 2018-10-16 | — | — | CN | disclosed |
| CN-105264086-B | method and kit for influenza diagnosis | 贝克顿·迪金森公司 | 2018-06-15 | — | — | CN | disclosed |
| US-20160041167-A1 | METHODS AND KITS FOR THE DIAGNOSIS OF INFLUENZA | BECTON, DICKINSON AND COMPANY | 2016-02-11 | — | — | US | disclosed |
| EP-2981618-A1 | METHODS AND KITS FOR THE DIAGNOSIS OF INFLUENZA | Becton, Dickinson and Company (US) | 2016-02-10 | — | — | EP | disclosed |
| CN-105264086-A | Method and kit for influenza diagnosis | BECTON DICKINSON CO | 2016-01-20 | — | — | CN | disclosed |
| WO-2014165536-A1 | METHODS AND KITS FOR THE DIAGNOSIS OF INFLUENZA | BECTON, DICKINSON AND COMPANY (US) | 2014-10-09 | — | — | WO | disclosed |
| US-8558004-B2 | Reagents and kits for detection of influenza virus and the like | CELLEX, INC. (US) | 2013-10-15 | — | — | US | disclosed |
| US-20110189655-A1 | REAGENTS AND KITS FOR DETECTION OF INFLUENZA VIRUS AND THE LIKE | CELLEX, INC. | 2011-08-04 | — | — | US | disclosed |
| US-7893272-B2 | Reagents and kits for detection of influenza virus and the like | CELLEX, INC. (US) | 2011-02-22 | — | — | US | disclosed |
| US-20080286758-A1 | REAGENTS AND KITS FOR DETECTION OF INFLUENZA VIRUS AND THE LIKE | CELLEX, INC. | 2008-11-20 | — | — | US | disclosed |
| WO-2007146197-A1 | METHODS AND REAGENTS FOR VIRUS ISOLATION AND DETECTION | LI XING-XIANG (US) | 2007-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110189655-A1 | REAGENTS AND KITS FOR DETECTION OF INFLUENZA VIRUS AND THE LIKE | ENGASE, NEU1, NEU4 | NANP 51/4885SELL 629/4885SELP 1810/4885 |
| US-11209433-B2 | Methods and kits for the diagnosis of influenza | NEU3, NEU1, ADA | NANP 80/4885SELL 1002/4885SELP 397/4885 |
| US-20160041167-A1 | METHODS AND KITS FOR THE DIAGNOSIS OF INFLUENZA | NEU3, NEU1, ADA | NANP 80/4885SELL 1002/4885SELP 397/4885 |
| US-20080286758-A1 | REAGENTS AND KITS FOR DETECTION OF INFLUENZA VIRUS AND THE LIKE | ENGASE, NEU1, NEU4 | NANP 51/4885SELL 629/4885SELP 1810/4885 |
| US-20190339272-A1 | METHODS AND KITS FOR THE DIAGNOSIS OF INFLUENZA | NEU3, NEU1, ADA | NANP 80/4885SELL 1002/4885SELP 397/4885 |
| US-10317404-B2 | Method and kits for the diagnosis of influenza | NEU3, NEU1, ADA | NANP 80/4885SELL 1150/4885SELP 431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.